Skip to : [Content] [Navigation]
 

Originally Published MX May/June 2006

BUSINESS NEWS

Majority of Top 20 Medtech Companies Post Double-Digit Sales Growth in 2005

Continuing a well-established pattern of financial performance that is relatively free from the cyclical nature of many high-technology sectors, the world's leading public medical device manufacturers generally experienced a good year in 2005, with 12 of the top 20 companies posting double-digit revenue gains over 2004 (see Table). All are listed on the New York Stock Exchange.

Company
2005 Revenues
($ billions)
2004 Revenues
($ billions)
Variance
(%)
Stock Symbol
(all NYSE)
Johnson & Johnson
19.096
16.887
6.7
JNJ
GE Healthcare
15.153
13.456
12.6
GE
Medtronic1
11.003
9.942
10.7
MDT
Baxter International Inc.
9.849
9.509
3.6
BAX
Tyco Healthcare
9.511
9.250
2.8
TYC
Siemens Medical Solutions2
9.481
8.441
12.3
SI
Cardinal Health3
8.476
7.358
15.2
CAH
Philips Medical Systems2
7.561
7.014
7.8
PHG
Boston Scientific Corp.
6.283
5.624
11.7
BSX
Abbott3
5.897
5.174
14.0
ABT
Becton Dickinson & Co.
5.540
5.037
10.0
BDX
Stryker Corp.
4.872
4.262
14.3
SYK
3M Healthcare
4.373
4.230
3.4
MMM
Guidant Corp.
3.550
3.765
-5.7
GDT
Zimmer Holdings
3.286
2.981
10.4
ZMH
St. Jude Medical
2.915
2.294
27.1
STJ
Kodak Health Group
2.655
2.686
-1.2
EK
Smith & Nephew4
2.446
2.171
12.7
SNN
Beckman Coulter Inc.
2.444
2.408
1.5
BEC
Alcon Inc.
2.017
1.814
11.2
ACL
1Revenues for the 12-month period ending January 31, 2006
2Financial data originally reported in euros.
3Estimated; Abbott and Cardinal Health do not provide detailed data for their medical product sectors.
4Financial data originally reported in pounds.
Revenues of world's top 20 public medtech firms for the 12-month period ending December 31, 2005, regardless of fiscal year. Only divisions reporting medical product revenues are included; pharmaceutical, consumer-product, and healthcare services divisions are excluded. All financial data obtained from company financial reports.

The company showing the greatest year-over-year improvement is St. Jude Medical Inc. (St. Paul, MN), whose revenues soared from $2.29 billion to $2.92 billion—a gain of more than 27%. A good portion of St. Jude's growth is believed to be market share captured from Guidant Corp. (Indianapolis), which saw sales decline by 5.7% in the face of product failures and extensive recalls in its cardiac rhythm management line. The only other company to report declining revenues was Kodak Health Group, a unit of Eastman Kodak Co. (Rochester, NY), which reported a 1.2% slippage in the hotly contested medical imaging capital equipment market.

The orthopedics sector turned in impressive numbers, with Stryker Corp. (Kalamazoo, MI), Smith & Nephew plc (London), and Zimmer Holdings Inc. (Warsaw, IN) posting sales gains of 14.3%, 12.7%, and 10.4%, respectively. Johnson & Johnson Inc. (J&J; New Brunswick, NJ), GE Healthcare (Chalfont St. Giles, UK), and Medtronic Inc. (Minneapolis) held on to the top three spots again this year. T

he top 20 firms generated $136.4 billion in revenues during 2005, ranging from $2 billion in sales at Alcon Inc. (Hunenberg, Switzerland) to J&J's $19.1 billion. Only four of the market leaders are based outside the United States: Siemens Medical Solutions, a division of Siemens AG (Munich); Philips Medical Systems, a unit of Royal Philips Electronics (Amsterdam, The Netherlands); Smith & Nephew; and Alcon.

Copyright ©2006 MX